News & Updates

VTE prevention in pregnancy: Does heparin dose matter?
VTE prevention in pregnancy: Does heparin dose matter?
02 Aug 2022 byRoshini Claire Anthony

In pregnant women with a history of venous thromboembolism (VTE), receipt of low-molecular-weight heparin (LMWH) at either a weight-adjusted intermediate-dose or fixed low-dose during the antepartum and postpartum periods results in similar VTE incidence, according to findings of the Highlow study. However, there was a numerically lower incidence of VTE during the postpartum period with intermediate-dose LMWH.

VTE prevention in pregnancy: Does heparin dose matter?
02 Aug 2022
Neutrophils release more cytokines in DM, HFpEF patients
Neutrophils release more cytokines in DM, HFpEF patients
27 Jul 2022

In patients with type 2 diabetes mellitus (DM) or heart failure with preserved ejection fraction (HFpEF), neutrophils seem to secrete more cytokines, contributing to low-grade chronic inflammation, a recent study reports.

Neutrophils release more cytokines in DM, HFpEF patients
27 Jul 2022
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
26 Jul 2022 byRoshini Claire Anthony

The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.

Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
26 Jul 2022
Abdominal aortic calcification linked to CAD, CI in T2DM
Abdominal aortic calcification linked to CAD, CI in T2DM
26 Jul 2022

In patients with type 2 diabetes mellitus (T2DM), abdominal aortic calcification might be an important indicator of coronary artery disease (CAD) and cerebral infarction (CI), a new study has found.

Abdominal aortic calcification linked to CAD, CI in T2DM
26 Jul 2022
CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery
CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery
24 Jul 2022

For patients undergoing surgery for oesophageal and gastric cancer, cardiopulmonary exercise testing (CPET) appears to be a reliable predictor of major cardiovascular complications, as reported in a study.

CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery
24 Jul 2022